Crake Asset Management LLP Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Crake Asset Management LLP purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 284,912 shares of the healthcare conglomerate’s stock, valued at approximately $149,998,000. UnitedHealth Group comprises 14.3% of Crake Asset Management LLP’s holdings, making the stock its largest position.

A number of other institutional investors also recently bought and sold shares of UNH. PineStone Asset Management Inc. lifted its holdings in shares of UnitedHealth Group by 22.8% in the 4th quarter. PineStone Asset Management Inc. now owns 925,454 shares of the healthcare conglomerate’s stock valued at $487,224,000 after purchasing an additional 171,764 shares during the last quarter. MainStreet Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 7.3% in the 4th quarter. MainStreet Investment Advisors LLC now owns 17,548 shares of the healthcare conglomerate’s stock valued at $9,238,000 after purchasing an additional 1,196 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $3,722,000. Norges Bank purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $5,802,231,000. Finally, Prestige Wealth Management Group LLC lifted its holdings in shares of UnitedHealth Group by 5.7% in the 4th quarter. Prestige Wealth Management Group LLC now owns 3,838 shares of the healthcare conglomerate’s stock valued at $2,021,000 after purchasing an additional 208 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on UNH shares. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target on the stock in a research report on Thursday, April 4th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Stephens restated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Finally, TD Cowen dropped their target price on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

View Our Latest Report on UnitedHealth Group

UnitedHealth Group Price Performance

UNH stock traded up $3.36 on Friday, reaching $524.63. The company had a trading volume of 2,657,396 shares, compared to its average volume of 3,305,639. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company’s fifty day moving average is $486.41 and its 200 day moving average is $511.17. The company has a market cap of $482.86 billion, a P/E ratio of 32.07, a PEG ratio of 1.52 and a beta of 0.55.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the prior year, the company earned $6.26 EPS. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.